Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersimmon Regulatory News (PSN)

Share Price Information for Persimmon (PSN)

Share Price is delayed by 15 minutes
Get Live Data
1,078.50    26.00 (2.47%)
Bid:
1,071.00
Ask:
1,072.00
Spread: 1.00 (0.093%)
Market Cap: £3.46b
PSN Live PriceLast checked at - London Stock Exchange

Intraday Persimmon Share Chart

Trading Statement

2 Jul 2013 07:00

RNS Number : 3375I
Persimmon PLC
02 July 2013
 



TRADING UPDATE

 

TUESDAY 2 JULY 2013

 

 

Persimmon plc announces the following update ahead of its Half Year Results to 30 June 2013, which will be released on Tuesday 20 August 2013.

 

The Group legally completed 5,022 new homes (2012: 4,712) in the first six months of the current year, an increase of 7% on the first half of 2012.

 

Visitors to our sites during the first half of the year were 13% stronger than the prior year and cancellation rates remained at historically low levels of 16% (2012: 18%). Throughout the period there has been an improvement in the availability of mortgage credit and a gradual reduction in mortgage interest costs supported by the Government's Funding for Lending Scheme.

 

Our average selling price of c. £179,200 (2012: £171,206) for the first six months was c. 5% ahead of last year mainly due to the continuing increase in the proportion of larger family housing in the sales mix. Underlying pricing remained stable throughout the period. Total revenues for the first half of the year of c. £900 million were c. 12% higher than last year (2012: £806.7 million).

 

The Government's "Help to Buy" 20% shared equity scheme, introduced in April 2013, has generated a positive response from prospective homebuyers, bringing additional momentum to the traditionally stronger spring sales season. Persimmon has secured 1,124 Help to Buy reservations since launch. Whilst our weekly private sale reservation rate for the first half of the year was 12% ahead of last year, our reservation rate as measured from the date of introduction of the "Help to Buy" scheme was 30% stronger. 

 

We are encouraged by the gradual increase in the number of major mortgage lenders supporting this Government initiative and anticipate that all the major lenders will be providing "Help to Buy" related mortgage products over the coming weeks. This will present a wider choice to customers and will help to support further increases in new home sales.

 

At 30 June the value of our forward sales of c. £920 million was c. 19% ahead of the prior year (2012: £774 million). Our private sale forward revenue was c. 24% ahead of last year whilst the value of our housing association forward sales increased by c. 10%.

 

In line with our plans, we have successfully opened 90 sites during the first half of the year. At 30 June we were operating from 385 active sites having fully sold through a number of existing sites a little earlier than anticipated due to the improved rate of sale we have experienced so far this year. 

 

Maintaining this strong nationwide outlet network remains a key feature of our long term strategy, sales growth being largely secured through improvements in weekly sales rates. We believe this increase will support higher levels of return on capital on a sustainable basis, delivering greater free cash net inflows.

 

We plan to open a further c. 85 new sites in the second half of the year and expect our active outlet network to remain stable at c. 385 sites through this six month period. While the process of achieving outline planning consents has continued to improve as a result of the Government's new National Planning Policy Framework, the volume of pre-start conditions is delaying progress on a number of these developments.

 

In line with our stated strategy we continue to improve our margins. We had expected to return to underlying operating margins of between 15% to 17% by the end of 2014. However, we are pleased to report that we now expect our underlying operating margin to have increased to c. 15% in the first half of this year, an increase of c. 280 basis points over the first half of last year (2012: 12.1% restated*). 

 

We have continued to invest in the future growth of the business, acquiring c. 7,300 new plots and investing c. £240 million in our land bank which totals c. 70,500 consented plots at 30 June 2013 (December 2012: 68,200). We have had good success in converting our strategic land which accounts for c. 20% of the new replacement plots acquired. We plan to bring these new sites through into development as quickly as possible.

 

The first payment of our Capital Return Plan of c. £228 million, or 75p per share, was made on 28 June 2013 having received shareholders' approval at the General Meeting on 18 April 2013. 

 

The growth of the business in terms of both revenue and profitability delivered c. £72 million of free cash net inflow before capital returns in the first six months of the year (2012: £112 million). At 30 June cash holdings totalled c. £45 million (2012: £135 million).

 

We have now entered the slower summer weeks for the UK housing market and continue to experience stable conditions. In the context of the wider economic challenges consumer confidence remains fragile. However, we remain focussed on the delivery of the planned further growth of Persimmon and the successful execution of our long term strategy.

 

We will announce our Half Year Results on Tuesday 20 August 2013 and will provide further details at that time.

 

* 2012 comparatives restated for amendment to IAS19 "Employee Benefits".

 

Please Note

 

There will be a call for analysts at 09:00 BST today. Please use the dial-in details below:

 

Telephone number: +44 (0)20 3003 2666

Conference code: Persimmon

 

An audiocast of the call will be available on www.corporate.persimmonhomes.com from this afternoon.

 

For further information, please contact:

 

Persimmon plc Citigate Dewe Rogerson

Jeff Fairburn, Group Chief Executive Simon Rigby

Mike Killoran, Group Finance Director Kevin Smith

Tel: +44 (0)1904 642199 Tel: +44 (0)20 7638 9571

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTRBMFTMBMMBFJ
Date   Source Headline
1st May 20257:00 amRNSAGM Trading Statement
25th Apr 202510:54 amRNSHolding(s) in Company
25th Apr 20259:24 amRNSHolding(s) in Company
11th Apr 20254:22 pmRNSHolding(s) in Company
3rd Apr 202510:15 amRNSHolding(s) in Company
2nd Apr 202512:22 pmRNSHolding(s) in Company
1st Apr 202512:03 pmRNSTotal Voting Rights
31st Mar 20253:14 pmRNSDirector/PDMR Shareholding
27th Mar 202510:08 amRNSHolding(s) in Company
25th Mar 20253:14 pmRNSDirector/PDMR Shareholding
24th Mar 20253:35 pmRNSAnnual Report 2024 and Notice of AGM 2025
24th Mar 20252:24 pmRNSHolding(s) in Company
11th Mar 20257:00 amRNSFull Year Results
6th Mar 20252:06 pmRNSHolding(s) in Company
3rd Mar 20253:35 pmRNSHolding(s) in Company
3rd Feb 202512:26 pmRNSTotal Voting Rights
14th Jan 20257:00 amRNS2024 Trading Statement
2nd Jan 20251:00 pmRNSTotal Voting Rights
10th Dec 20243:47 pmRNSDirectorate Change
2nd Dec 20242:11 pmRNSBlock listing Interim Review
2nd Dec 202412:00 pmRNSTotal Voting Rights
6th Nov 20247:00 amRNSQ3 Trading Statement
5th Nov 20241:31 pmRNSHolding(s) in Company
1st Nov 20243:59 pmRNSTotal Voting Rights
1st Oct 20241:19 pmRNSTotal Voting Rights
24th Sep 202412:25 pmRNSDirector/PDMR Shareholding
2nd Sep 20241:44 pmRNSTotal Voting Rights
8th Aug 20247:00 amRNSHalf Year Results
1st Aug 20242:32 pmRNSTotal Voting Rights
23rd Jul 202410:28 amRNSDirectorate Change
1st Jul 20241:10 pmRNSTotal Voting Rights
19th Jun 20242:48 pmRNSDirector/PDMR Shareholding
3rd Jun 202412:33 pmRNSBlock listing Interim Review
3rd Jun 202411:08 amRNSTotal Voting Rights
23rd May 20247:00 amRNSConfirmation of CFO start date
1st May 20241:11 pmRNSTotal Voting Rights
30th Apr 20242:03 pmRNSDirectorate Change
25th Apr 20242:09 pmRNSResult of AGM
25th Apr 20247:00 amRNSQ1 Trading Statement
2nd Apr 20241:49 pmRNSTotal Voting Rights
28th Mar 202412:53 pmRNSDirector/PDMR Shareholding
25th Mar 20244:47 pmRNSDirector/PDMR Shareholding
25th Mar 20242:07 pmRNSAnnual Report 2023 and Notice of AGM 2024
12th Mar 20241:38 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSFull Year Results
11th Jan 20246:00 pmRNSDechra Pharmaceuticals
10th Jan 20247:00 amRNSTrading Statement
1st Dec 20234:48 pmRNSBlock listing Interim Review
1st Dec 20234:45 pmRNSTotal Voting Rights
17th Nov 202310:25 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.